Skip to main content

Search articles in

Found 3,297 articles

  • About HUTCHMED

    About HUTCHMED

    • 12 Jul 2024
    • Editor

    HUTCHMED (Nasdaq/AIM:HCM; HKEX:13) is an innovative, commercial-stage, biopharmaceutical company. It is committed to the discovery and global development and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases.

  • Danaher Launches Beacon Research Collaboration wit

    Danaher Launches Beacon Research Collaboration with Stanford University Aiming to Build Next Generation of Smart Microscopes for Cancer Drug Screening

    • 12 Jul 2024
    • Editor

    Danaher Corporation (NYSE: DHR), a global science and technology innovator, today launched a research collaboration with Stanford University's Department of Bioengineering intended to shape the future of cancer drug screening through "smart microscopy."

  • Thermo Fisher Scientific to Help Advance Myeloid C

    Thermo Fisher Scientific to Help Advance Myeloid Cancer Clinical Research and Treatment Utilizing Next Generation Sequencing Technology

    • 12 Jul 2024
    • Editor

    To help accelerate research into new treatments for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS), Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, is partnering with the National Cancer Institute (NCI) – part of the National Institutes of Health – on the myeloMATCH (Molecular Analysis for Therapy Choice) precision medicine umbrella trial.

  • Labcorp and Naples Comprehensive Healthcare Announ

    Labcorp and Naples Comprehensive Healthcare Announce Strategic Agreement for Lab Operations

    • 12 Jul 2024
    • Editor

    Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, has entered into a comprehensive strategic collaboration with Naples Comprehensive Healthcare (NCH) in Southwest Florida to manage the daily operations of NCH’s inpatient lab operations. Separately, Labcorp will begin to serve as the primary lab for NCH’s physician network later this summer.

  • IQVIA Named a Leader in Medical Affairs and Regula

    IQVIA Named a Leader in Medical Affairs and Regulatory Operations by Everest Group

    • 12 Jul 2024
    • Editor

    IQVIA™ (NYSE:IQV) today announces that a leading, independent research firm, Everest Group, has recognized IQVIA as a Leader in its Life Sciences Regulatory and Medical Affairs Operations PEAK Matrix® Assessment 2024 survey, which measures both market impact and delivery effectiveness.

  • What Does a Bioinformatician Do?

    What Does a Bioinformatician Do?

    • 11 Jul 2024
    • Lucy Walters

    Bioinformatics is an interdisciplinary field that integrates computer science, mathematics, statistics, and biology to manage and analyse biological data. This field is crucial to the life sciences industry for its role in understanding complex biological processes, leading to significant advances in drug discovery, genetic research, and personalised medicine.

  • London-based AI platform celebrated at prestigious

    London-based AI platform celebrated at prestigious technologies competition

    • 11 Jul 2024
    • Editor

    A London-based AI-driven pharmaceutical company, Ignota Labs, that could transform the world around us has been named a winner of the Royal Society of Chemistry’s 2024 Emerging Technologies Competition.

  • About Calliditas Therapeutics

    About Calliditas Therapeutics

    • 11 Jul 2024
    • Editor

    Calliditas Therapeutics is a biopharma company headquartered in Stockholm, Sweden, focused on identifying, developing, and commercializing novel treatments in orphan indications with significant unmet medical needs. Calliditas’ common shares are listed on Nasdaq Stockholm (ticker: CALTX) and its American Depositary Shares are listed on the Nasdaq Global Select Market (ticker: CALT). Visit Calliditas.com for further information.

  • Pfizer to Launch Process to Identify a Successor f

    Pfizer to Launch Process to Identify a Successor for Dr. Mikael Dolsten, Chief Scientific Officer and President, Pfizer Research & Development

    • 11 Jul 2024
    • Editor

    Pfizer Inc. (NYSE: PFE) today announced that the company is launching the process to identify a successor for Dr. Mikael Dolsten, Pfizer’s Chief Scientific Officer and President, Pfizer Research & Development, who will depart the company after a more than 15-year stellar career.

  • ICON recognised for leadership position in clinica

    ICON recognised for leadership position in clinical research industry and as socially responsible employer

    • 11 Jul 2024
    • Editor

    ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured in the first half of 2024 with a number of leading business and industry awards recognising the company’s leadership position in the clinical research industry, in addition to its efforts in inclusion, sustainability and as an employer of choice.

  • AbbVie Announces Appointment of Roopal Thakkar, M.

    AbbVie Announces Appointment of Roopal Thakkar, M.D. as Executive Vice President, Research & Development and Chief Scientific Officer

    • 11 Jul 2024
    • Editor

    AbbVie (NYSE:ABBV) today announced that Roopal Thakkar, M.D. who currently serves as senior vice president, chief medical officer, global therapeutics has been appointed to the position of executive vice president, research & development and chief scientific officer. In this position, Dr. Thakkar will lead the company's global R&D organization of more than 14,000 team members across all phases of discovery and development, including therapeutics and aesthetics.

  • Cambridge Cognition secures Innovate UK grant to c

    Cambridge Cognition secures Innovate UK grant to collect multimodal data with a large patient sample in the Bio-Hermes 2 project

    • 11 Jul 2024
    • Editor

    Cambridge Cognition, a leading provider of digital health solutions for brain health assessments has been included in the Bio-Hermes 2 project for its voice and touch-screen cognitive assessments, funded by the UK’s innovation agency, Innovate UK.

  • Talent Retention Trends and Strategies

    Talent Retention Trends and Strategies

    • 10 Jul 2024
    • Kirsty Calow, Nexa Life Sciences

    There is no disputing that the industry has faced significant challenges over the last few years. Balancing this comes with its own set of difficulties. With previous funding shortages, shifting market demands, technological advancements, mergers and acquisitions, and widespread redundancies, it is hard not to empathise with the challenges employers and employees are currently facing.

  • About EuropaBio

    About EuropaBio

    • 10 Jul 2024
    • Editor

    EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 2600 biotech companies, 2300 out of them are SMEs. EuropaBio has a Board of Management made up of representatives of member companies.

  • Jazz Pharmaceuticals Promotes Samantha Pearce to C

    Jazz Pharmaceuticals Promotes Samantha Pearce to Chief Commercial Officer

    • 10 Jul 2024
    • Editor

    Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Samantha Pearce, Senior Vice President (SVP), Europe and International, has been promoted to Chief Commercial Officer (CCO) effective August 1, 2024.

  • Evotec and Pfizer collaborate to advance drug disc

    Evotec and Pfizer collaborate to advance drug discovery in France

    • 10 Jul 2024
    • Editor

    Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced it has entered into a multi-year master research collaboration and option and license agreement with Pfizer. Under the agreement, Evotec and Pfizer will initially focus on early discovery research for metabolic and infectious diseases.

  • About BioIndustry Association (BIA)

    About BioIndustry Association (BIA)

    • 9 Jul 2024
    • Editor

    The BioIndustry Association (BIA) is the voice of the innovative life sciences and biotech industry, enabling and onnecting the UK ecosystem so that businesses can start, grow and deliver world-changing innovation. Helping biotech and life sciences sector to influence, connect and save.

  • Curve Therapeutics strengthens Leadership Team wit

    Curve Therapeutics strengthens Leadership Team with appointment of experienced biotech executive Simon Jones

    • 9 Jul 2024
    • Editor

    Curve Therapeutics (“Curve” or the “Company”), a private biotechnology company pioneering a revolutionary intracellular screening platform addressing complex and challenging disease targets, today announces the appointment of Simon Jones as Chief Financial Officer (CFO) and Chief Operating Officer (COO).

  • Allucent Awarded 5-Year BARDA Agreement Aimed at E

    Allucent Awarded 5-Year BARDA Agreement Aimed at Enhancing and Accelerating Decentralized Clinical Trials for Medical Countermeasure Development

    • 9 Jul 2024
    • Editor

    Allucent, a global mid-sized clinical research organization (CRO), announced today that it has been selected by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services, for its new Decentralized Clinical Operations for Healthcare and Research (D-COHRe) initiative.

  • Roche receives CE Mark for its AI-enabled continuo

    Roche receives CE Mark for its AI-enabled continuous glucose monitoring solution offering critical predictions to people living with diabetes

    • 9 Jul 2024
    • Editor

    Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received the CE Mark for its Accu-Chek SmartGuide® continuous glucose monitoring (CGM) solution. This significant milestone paves the way for the solution to be made available to people living with type 1 and type 2 diabetes over the age of 18 on flexible insulin therapy.